Italy launched a project for building a new national cross-disciplinary research institute focused on life sciences, called Human Technopole (HT).

U.S. businesses interested in Vietnam’s healthcare market may enter by appointing an agent/distributor or directly by establishing a commercial operation.

A summary of what companies will need to do in order to place a medical device on the Great Britain (England, Wales and Scotland) and Northern Ireland markets from January 2021. 

Indonesia’s national public procurement agency announced its enrollment of medicines and medical devices in its national e-Katalog system. 

India’s nutraceutical industry is expected to hold at least 3.5 percent of global market share by 2023.

Taiwan is a stable and growing market for innovative medical devices and products. 

The Australian healthcare industry is dependent on imported equipment and demand is high for high quality, innovative dental products. 

The Qatari government recently enacted a law governing public-private partnerships (PPPs) signaling to U.S. firms access to the government of Qatar on infrastructure development opportunities. 

South Africa announces the establishment of a Technology Innovation Cluster.

A recent poll on telemedicine in Austria offers valuable takeaways for U.S. vendors.

U.S. eHealth companies with globally competitive products and services should consider customizing for the unique Swedish market.

Major suppliers to the medical devices in Portugal are: U. S. Germany, France and Japan. Increased opportunities for U.S. manufacturers are expected in coming years.

The United Arab Emirates is investing in Health IT products and services for electronic medical records (EMR), telemedicine, smart health & apps to improve efficiencies and improve patient health and safety. 

Japan implemented the second phase of its five-year health and medical strategy designed to advance healthcare industry developments in Japan and will give US companies insight into potential opportunities in the Japanese market. 

Japan’s Pharmaceutical and Medical Devices Law (PMD Law) improves the regulatory environment for medical devices.